151 related articles for article (PubMed ID: 3898761)
1. Insulin-stimulated glucose disposal in patients with type I (IDDM) and type II (NIDDM) diabetes mellitus.
Reaven GM
Adv Exp Med Biol; 1985; 189():129-36. PubMed ID: 3898761
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
3. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
[TBL] [Abstract][Full Text] [Related]
4. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
Reaven GM
Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
[TBL] [Abstract][Full Text] [Related]
6. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies.
Goldfine AB; Simonson DC; Folli F; Patti ME; Kahn CR
J Clin Endocrinol Metab; 1995 Nov; 80(11):3311-20. PubMed ID: 7593444
[TBL] [Abstract][Full Text] [Related]
8. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
9. Role of insulin resistance in the pathogenesis of NIDDM.
Yki-Järvinen H
Diabetologia; 1995 Dec; 38(12):1378-88. PubMed ID: 8786010
[TBL] [Abstract][Full Text] [Related]
10. Chronic effects of tolbutamide on myocardial tension during ischemia and reperfusion in perfused hearts isolated from insulin dependent and non insulin dependent diabetic rats.
Oshiro K; Murakami K; Sunagawa R; Mimura G
Jpn Heart J; 1991 May; 32(3):347-61. PubMed ID: 1920821
[TBL] [Abstract][Full Text] [Related]
11. Factors related to glycemic control in IDDM and insulin-treated NIDDM patients in current practice. A comparison of care policies. SIEMTIC Group. Studio Italiano Epidemiologico Multicentrico su Terapia Insulin e Controllo Metabolico.
Garancini MP; Gallus G; Cucinotta D; Rossi A; Riccardi G
Diabetes Care; 1997 Nov; 20(11):1659-63. PubMed ID: 9353604
[TBL] [Abstract][Full Text] [Related]
12. Influence of oral sulfonylurea agents on hepatic glucose uptake.
Kawamori R; Morishima T; Kubota M; Matsuhisa M; Ikeda M; Kamada T
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S109-13. PubMed ID: 8529503
[TBL] [Abstract][Full Text] [Related]
13. [Glucose toxicity--pros and cons. Useful adaptation and common cause of insulin resistance in diabetic patients].
Yki-Järvinen H
Nord Med; 1996 Mar; 111(3):80-3. PubMed ID: 8628644
[TBL] [Abstract][Full Text] [Related]
14. The glycemic index: similarity of values derived in insulin-dependent and non-insulin-dependent diabetic patients.
Wolever TM; Jenkins DJ; Josse RG; Wong GS; Lee R
J Am Coll Nutr; 1987 Aug; 6(4):295-305. PubMed ID: 3611527
[TBL] [Abstract][Full Text] [Related]
15. Complements in diabetes mellitus: activation of complement system evidenced by C3d elevation in IDDM.
Morimoto Y; Taniguchi H; Yamashiro Y; Ejiri K; Baba S; Arimoto Y
Diabetes Res Clin Pract; 1988 Oct; 5(4):309-12. PubMed ID: 3266138
[TBL] [Abstract][Full Text] [Related]
16. Can insulin resistance exist as a primary defect in noninsulin-dependent diabetes mellitus?
Swislocki AL; Donner CC; Fraze E; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1987 Apr; 64(4):778-82. PubMed ID: 3546354
[TBL] [Abstract][Full Text] [Related]
17. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid.
Jacob S; Henriksen EJ; Tritschler HJ; Augustin HJ; Dietze GJ
Exp Clin Endocrinol Diabetes; 1996; 104(3):284-8. PubMed ID: 8817248
[TBL] [Abstract][Full Text] [Related]
18. Current state of metabolic control achieved in a New Zealand diabetes clinic.
Dunn PJ
N Z Med J; 1996 Mar; 109(1018):98-101. PubMed ID: 8606845
[TBL] [Abstract][Full Text] [Related]
19. How insulin resistant are patients with noninsulin-dependent diabetes mellitus?
Reaven GM; Chen YD; Donner CC; Fraze E; Hollenbeck CB
J Clin Endocrinol Metab; 1985 Jul; 61(1):32-6. PubMed ID: 3889039
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of insulin secretion in diabetes mellitus.
Ward WK; Beard JC; Halter JB; Porte D
Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
